High-Capacity Adenoviral Vectors: Expanding the Scope of Gene TherapyReview Published on 2020-05-212022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, [키워드] adenoviral vector Adenovirus Better cells coding sequence contribute Efficacy feature gene correction gene delivery Gene therapy Genetic Genome gutless helper-dependent high-capacity adenovirus implementation in vivo Inflammatory response lack limitation overcome persistence platform reliability required Research stability therapeutic transgene vector vectors [DOI] 10.3390/ijms21103643 PMC 바로가기 [Article Type] Review
Better preventing and mitigating the effects of Covid-19Special Report Published on 2020-05-202022-10-31 Journal: Future Science OA [Category] COVID-19, [키워드] Abstract addition Better Complete COVID-19 diet disease Effect ENhance exposome fiber immune system Immunity include Infection Inflammation insoluble medical treatment mitigate plants Prevent Probability public health measure reduce reduced reduction responsible SARS-CoV-2 SARS-COV-2 infection severity Spread the disease virus [DOI] 10.2144/fsoa-2020-0051 PMC 바로가기 [Article Type] Special Report
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 PandemicCommunication Published on 2020-05-022022-10-30 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] artificial artificial intelligence Better big data Can COVID-19 COVID-19 pandemic effort Epidemic Epidemiology handling Health help information intelligence molecular Novel coronavirus Organisms outbreak pandemic public health responsible SARS-CoV2 Surveillance viral outbreak World Health Organization [DOI] 10.3390/ijerph17093176 PMC 바로가기 [Article Type] Communication
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO ModelOncology Published on 2020-04-222022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] acute respiratory syndrome administration Admission anticancer applied benefit Better Cancer Care China clinical conditions Comorbidities concerning Containment containment measures Contamination coronavirus coronavirus disease country Course COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 severity disease Elderly patient European expected Follow-up visit high risk histology hospital hospitals Infection International Interstitial lung disease Italy lung cancer lung cancer patient management measure media Model Mortality myelosuppression National Novel coronavirus oncologist oncology organization pandemic Patient Potential PROTECT pulmonary complication receiving recommendation reported required Result risk SARS-CoV-2 SARS-CoV2 infection significantly Spread suspected patient Symptom the disease Toxicity Treatment WHO with COVID-19 World Health Organization [DOI] 10.3389/fonc.2020.00665 PMC 바로가기 [Article Type] Oncology
Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa남아프리카 공화국의 HIV 예방 시험 네트워크 071(PopART) 시험에서 인간 면역 결핍 바이러스(HIV)를 가지고 사는 사람들 사이에서 더 나은 바이러스학적 결과가 조기 항레트로바이러스 치료(CD4 카운트 ≥500 세포/μL)를 시작합니다Articles and Commentaries Published on 2020-02-012022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] adjusted hazard ratio adjusted relative risk Antiretroviral therapy ART baseline CD4 baseline CD4 cell baseline CD4 cell count Better CD4 CD4 count CD4 counts clinical clinically confidence interval count early antiretroviral treatment elevated hazard ratio HIV HIV/AIDS HPTN 071 (PopART) Trial Human Human immunodeficiency virus immunodeficiency virus implementation incidence rate Initiating International interval National network participant Participants pre-ART CD4 pre-ART CD4 cell prevention prospective cohort study provided reduced Registration Relative risk Result risk South Africa Trial universal ART Viral Viral load virological failure virological outcome virological outcomes virological suppression [DOI] 10.1093/cid/ciz214 PMC 바로가기 [Article Type] Articles and Commentaries
Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis?뇌내 사이토카인 반응이 인간 면역결핍 바이러스 관련 크립토코커스 수막염에서 덱사메타손의 유해한 영향을 설명합니까?Articles and Commentaries Published on 2019-05-012022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] 95% confidence interval analyzed association baseline Better caused cerebrospinal fluid clearance clinical impact Clinical outcome colony-stimulating factor Concentration concentrations correlation Corticosteroids Cox regression models cryptococcal cryptococcal meningitis CSF cytokine Cytokines Decline Dexamethasone Effect faster following fungal Genotype granulocyte granulocyte-macrophage colony-stimulating factor had no Human Human immunodeficiency virus immunodeficiency Impact inflammatory protein Interaction interferon interferon γ interleukin interleukin 6 investigated leukotriene leukotriene A4 hydrolase LTA4H Macrophage macrophage inflammatory protein 1α mechanism Meningitis monocyte Necrosis outcome participant polymorphism Proinflammatory cytokine promoter region reduced response Result single-nucleotide single-nucleotide polymorphism statistically significant therapy TNF TNF-α Treatment Trial tuberculous tuberculous meningitis Tumor tumor necrosis tumor necrosis factor tumor necrosis factor α Uganda [DOI] 10.1093/cid/ciy725 PMC 바로가기 [Article Type] Articles and Commentaries
Growth enhancement of porcine epidemic diarrhea virus (PEDV) in Vero E6 cells expressing PEDV nucleocapsid proteinResearch Article Published on 2019-03-062022-10-28 Journal: PLoS ONE [Category] Coronavirus, MERS, [키워드] accelerate affected assist Better Cell culture cell culture systems clone demonstrated diarrhea economic loss effective ENhance epidemic diarrhea expressing growth high mortality rate magnitude N expression Nidovirale nucleocapsid nucleocapsid protein outbreak Pathogens PEDV platform Protein Replication reproductive respiratory virus strain vaccine candidate Vaccine development vaccine production Vaccines Vero E6 cell VERO E6 cells virus virus production [DOI] 10.1371/journal.pone.0212632 PMC 바로가기 [Article Type] Research Article
Temporal Variability and Social Heterogeneity in Disease Transmission: The Case of SARS in Hong KongResearch Article Published on 2009-08-212022-10-28 Journal: PLoS Computational Biology [Category] Coronavirus, MERS, [키워드] acute respiratory syndrome Affect applied Author average behavioural Better case change changes in Community Contact Course Critical different disease transmission effective Epidemic Epidemics epidemiological estimate event Evolution example functions General population healthcare healthcare worker Hong Kong hospital Hospitalized hospitals infect infectious influenza pandemic Markov chain mean measure observation outbreak parameter parameters Probability PROTECT provided public health measure recent reduced remained Reproduction number risk of infection SEIR shown subpopulation susceptible-exposed-infectious-removed sustained Temporal the SARS epidemic Transmission transmission rates was used were infected [DOI] 10.1371/journal.pcbi.1000471 PMC 바로가기 [Article Type] Research Article